Bilipro®Daily The average percentage of effectiveness
Reducing symptoms of inflammatory bowel disease (IBD), such as ulcerative colitis, preventing disease relapse, and aiding in the treatment of chronic pouchitis.
96%
Reducing symptoms of inflammatory bowel disease (IBD), including ulcerative colitis, preventing disease relapse, and assisting in the treatment of chronic pouchitis.
81%
Enhance the strength of the immune system.
86%
Alleviating symptoms of irritable bowel syndrome (IBS) by reducing abdominal pain, bloating, and constipation, as well as decreasing the frequency of bowel movements and improving stool consistency.